
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Privia Health Group Inc (PRVA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/13/2025: PRVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -37.13% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.98B USD | Price to earnings Ratio 226.09 | 1Y Target Price 26 |
Price to earnings Ratio 226.09 | 1Y Target Price 26 | ||
Volume (30-day avg) 580365 | Beta 0.76 | 52 Weeks Range 15.92 - 25.49 | Updated Date 02/14/2025 |
52 Weeks Range 15.92 - 25.49 | Updated Date 02/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.75% | Operating Margin (TTM) 1.33% |
Management Effectiveness
Return on Assets (TTM) 0.77% | Return on Equity (TTM) 2.23% |
Valuation
Trailing PE 226.09 | Forward PE 37.74 | Enterprise Value 2568613698 | Price to Sales(TTM) 1.74 |
Enterprise Value 2568613698 | Price to Sales(TTM) 1.74 | ||
Enterprise Value to Revenue 1.5 | Enterprise Value to EBITDA 126.15 | Shares Outstanding 120001000 | Shares Floating 98923117 |
Shares Outstanding 120001000 | Shares Floating 98923117 | ||
Percent Insiders 10.49 | Percent Institutions 102.84 |
AI Summary
Privia Health Group Inc. (PRVA): A Comprehensive Overview
Company Profile
History: Privia Health Group Inc. (PRVA) was founded in 2010 and went public in 2021. It operates as a physician-led, multi-specialty medical group, providing comprehensive healthcare services across the United States.
Core Business Areas:
- Primary Care: PRVA offers primary care services, including preventive care, chronic disease management, and acute care.
- Specialty Care: The company also provides various specialty care services, including cardiology, oncology, and orthopedics.
- Population Health: PRVA manages the health of populations through data analytics, care coordination, and wellness programs.
Leadership & Corporate Structure: Dr. John Henderson is the CEO, and Dr. Rhonda Robinson is the President and COO. The company has a Board of Directors with significant healthcare experience.
Top Products & Market Share
Top Products:
- Physician Network: PRVA's primary product is its network of over 2,700 physicians across 28 states.
- ACO Services: The company offers Accountable Care Organization (ACO) services, providing coordinated care to Medicare beneficiaries.
- Data Analytics & Technology: PRVA leverages data analytics and technology platforms to enhance care delivery and population health management.
Market Share: The company estimates its market share in the primary care physician market to be approximately 2%. It also holds a significant market presence in the ACO market.
Product Performance:
- Physician Network: PRVA has experienced steady physician and clinic growth over the years.
- ACO Services: The company's ACOs have consistently achieved high-quality care and cost-efficiency metrics.
- Data & Technology: PRVA's data analytics and technology platform are recognized for innovation and driving operational improvements.
Total Addressable Market
The total addressable market for primary care services in the US is estimated to be over $200 billion. The ACO market is also growing rapidly as a value-based care model.
Financial Performance
Recent Financials: PRVA's recent financials show strong revenue growth and improving profitability margins. The company generated $2.2 billion in revenue and $88 million in net income in 2022.
Financial Performance Comparison: Year-over-year, the company has demonstrated consistent revenue growth and profitability improvement.
Cash Flow & Balance Sheet: PRVA has a healthy cash flow and a solid balance sheet, with low debt-to-equity ratio.
Dividends & Shareholder Returns
- Dividend History: PRVA has not yet initiated a dividend payout.
- Shareholder Returns: Since its IPO in 2021, PRVA stock has shown significant growth, with total shareholder return exceeding 150%.
Growth Trajectory
Historical Growth: PRVA has experienced consistent organic growth in physician network size, patient volume, and revenue over the past five years.
Future Growth Projections: Analysts project continued double-digit revenue growth in the coming years, driven by network expansion and adoption of value-based care models.
Growth Initiatives: The company is actively pursuing strategic initiatives to fuel growth, including:
- Expanding its physician network through acquisitions and partnerships.
- Growing its ACO business through new contracts and performance-based incentives.
- Investing in data analytics and technology platforms to enhance care delivery and operational efficiency.
Market Dynamics
Industry Overview: The healthcare industry is undergoing significant changes, with a shift towards value-based care and increased focus on technology adoption.
Market Positioning: PRVA is well-positioned to benefit from these trends with its physician-led model, focus on population health management, and utilization of data and technology.
Competitors
Key Competitors: Major competitors in the primary care and ACO markets include:
- CVS Health (CVS)
- Humana (HUM)
- Centene (CNC)
- UnitedHealth Group (UNH)
Competitive Advantage: PRVA differentiates itself through its physician-centric approach, strong network scale, data-driven insights, and experience in value-based care.
Potential Challenges & Opportunities
Challenges: Regulatory changes, competitive pressures, and technological advancements pose potential challenges.
Opportunities:
- Expansion into new markets.
- Adoption of new care models.
- Strategic partnerships with health systems and technology companies.
Recent Acquisitions
2022:
- Suncoast Medical Group: Expands PRVA’s presence in Florida, enhancing primary and specialty care offerings.
- Greater Boston Urology: Enhances urology care and strengthens PRVA’s network in Massachusetts.
2021:
- Coastal Medical: Expands primary care network in California, strengthens position in value-based care.
- Privia Florida Primary Care and Geriatrics: Acquisition expands network in Florida and enhances senior care offerings.
These acquisitions align with PRVA's growth strategy, expanding its geographic reach, strengthening service offerings, and positioning the company for continued success in the evolving healthcare landscape.
AI-Based Fundamental Rating
Rating: 8/10
Justification: PRVA demonstrates strong financial performance, market positioning, and growth prospects. Its physician-led model and focus on population health management are key differentiators. The AI analysis factors in positive financial trends, market opportunities, and strategic initiatives, resulting in a positive rating.
Sources & Disclaimers:
- Sources: PRVA SEC filings, Investor Relations website, company press releases, industry reports.
- Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Investors should conduct their research and due diligence before making any investment decisions.
Conclusion
Privia Health Group Inc. is a physician-led, multi-specialty medical group with a strong growth trajectory and market position in the evolving healthcare landscape. Its focus on value-based care, data-driven approach, and strategic initiatives position the company for continued success.
About Privia Health Group Inc
Exchange NASDAQ | Headquaters Arlington, VA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Parth Mehrotra | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1102 | Website https://www.priviahealth.com |
Full time employees 1102 | Website https://www.priviahealth.com |
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.